Transactions
Feb. 29, 2000
Rapid Growth of IPO Is in Sequenoms Genes
Shearman & Sterling RAPID GROWTH OF IPO IS IN SEQUENOM'S GENES Redwood City's Sequenom began its initial public offering of 3.5 million shares of common stock. Though the proposed offering price was previously fixed between $23 and $25, the stock's first day closing price of $79.25 per share makes the offering worth as much as $420 million.
Shearman & Sterling
RAPID GROWTH OF IPO IS IN SEQUENOM'S GENES
Redwood City's Sequenom began its initial public offering of 3.5 million shares of common stock. Though the proposed offering price was previously fixed between $23 and $25, the stock's first day closing price of $79.25 per share makes the offering worth as much as ...
RAPID GROWTH OF IPO IS IN SEQUENOM'S GENES
Redwood City's Sequenom began its initial public offering of 3.5 million shares of common stock. Though the proposed offering price was previously fixed between $23 and $25, the stock's first day closing price of $79.25 per share makes the offering worth as much as ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In